Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Molecular and Cellular Biology
|
November 26, 2002
Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter
Mikael Sigvardsson, Dawn R Clark, Daniel Fitzsimmons, et al.
Clinical and Translational Medicine
|
March 1, 2013
Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
Charlotte Welinder, Göran Jönsson, Christian Ingvar, et al.
Gels (Basel, Switzerland)
|
October 28, 2025
The Potential of Dosimetry and the Visualization of Microbeam Arrays in NIPAM Gel at the PETRA III Synchrotron
Thomas Breslin, Malin Kügele, Vincent de Rover, et al.
Biomimetics (Basel, Switzerland)
|
June 27, 2023
A Novel Anthropomorphic Phantom Composed of Tissue-Equivalent Materials for Use in Experimental Radiotherapy: Design, Dosimetry and Biological Pilot Study
Thomas Breslin, Jason Paino, Marie Wegner, et al.
Journal of Proteome Research
|
February 5, 2014
Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification
Charlotte Welinder, Göran Jönsson, Christian Ingvar, et al.
Plos One
|
October 22, 2014
Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay
Charlotte Welinder, Göran B Jönsson, Christian Ingvar, et al.
Proteomics
|
July 22, 2014
A new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging
Yutaka Sugihara, Akos Végvári, Charlotte Welinder, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Molecular and Cellular Biology
|
November 26, 2002
Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter
Mikael Sigvardsson, Dawn R Clark, Daniel Fitzsimmons, et al.
Clinical and Translational Medicine
|
March 1, 2013
Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability
Charlotte Welinder, Göran Jönsson, Christian Ingvar, et al.
Gels (Basel, Switzerland)
|
October 28, 2025
The Potential of Dosimetry and the Visualization of Microbeam Arrays in NIPAM Gel at the PETRA III Synchrotron
Thomas Breslin, Malin Kügele, Vincent de Rover, et al.
Biomimetics (Basel, Switzerland)
|
June 27, 2023
A Novel Anthropomorphic Phantom Composed of Tissue-Equivalent Materials for Use in Experimental Radiotherapy: Design, Dosimetry and Biological Pilot Study
Thomas Breslin, Jason Paino, Marie Wegner, et al.
Journal of Proteome Research
|
February 5, 2014
Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification
Charlotte Welinder, Göran Jönsson, Christian Ingvar, et al.
Plos One
|
October 22, 2014
Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay
Charlotte Welinder, Göran B Jönsson, Christian Ingvar, et al.
Proteomics
|
July 22, 2014
A new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging
Yutaka Sugihara, Akos Végvári, Charlotte Welinder, et al.
Page
of 2